Abstract:Objective: The study was designed to evaluate the effect of follicular fluid from patients with endometriosis, follicle stimulating hormone (FSH), bone morphogenetic protein 15 (BMP-15) on the proliferation and progesterone secretion of human luteinized granular cells in vitro. Methods: Cumulus granulosa cells were collected from the patients who underwent in vitro fertilization and embryo transfer (IVF-ET) ovulation due to tubal or male factor infertility on the day of the retrieval. The cells in the control group were cultured with complete medium of DMEM/F-12, an extra of FSH at a dose of 12 μg/L was added in the FSH group, an extra of BMP-15 at a dose of 6 μg/L was added to the BMP-15 group, an extra of 5% of the follicular fluid from the patients with tubal or male factor infertility was added to the tubal group, an extra of 5% of the follicular fluid from the patients with endometriosis infertility was added to the endometriosis group, an extra of 5% of the follicular fluid from the patients with endometriosis infertility plus FSH at a dose of 12 μg/L were added to the endometriosis plus FSH group, and an extra of 5% of the follicular fluid from the patients with endometriosis infertility plus BMP-15 at a dose of 6 μg/L were added to the endometriosis plus BMP-15 group. Hemacytometer counting method was used to observe the growth of cells after 48 hours, and chemiluminescence method was utilized to measure the level of progesterone in culture supernatant. Results: The cell proliferation was enhanced in the FSH group, while the proliferation was inhibited in the endometriosis group and the endometriosis plus BMP-15 group, compared to the control group, both of which, were statistically significant. Compared to the control group, the progesterone levels from the culture supernatant of granular cells were significantly elevated in the FSH group, tubal group and endometriosis group. The secretion of progesterone in the endometriosis group was lower than that in the tubal group. After addition of FSH into the endometriosis group (the endometriosis plus FSH group), the secretion level of progesterone was significantly increased, compared to the control group and the endometriosis group. After adding BMP-15 into the endometriosis group (the endometriosis plus BMP-15 group), the secretion level of progesterone was increased, compared to the control group. Conclusions: FSH, but not BMP-15, was able to enhance the proliferation and progesterone secretion of granular cells. The proliferation of granular cells and secretion of progesterone were inhibited by the follicular fluid from patients with endometriosis, which was reversed by FSH. However, BMP-15 had no effect on the outcome of follicular fluid from patients with endometriosis.

[Women with Poor Response to Ovarian Stimulation Have Increased Follicular Bone Morphogenetic Protein-15 Levels].

High Bone Morphogenetic Protein-15 Level in Follicular Fluid is Associated with High Quality Oocyte and Subsequent Embryonic Development

Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders

Influence of Bone Morphogenetic Protein(BMP)-15 on the IVF Outcomes of Endometriosis——A Clinical Trail and Experimental Research

Poor Ovarian Response To Gonadotropin Stimulation Is Associated With Low Expression Of Follicle-Stimulating Hormone Receptor In Granulosa Cells

[The Effect of Follicular Fluid from Patients with Endometriosis, Follicle Stimulating Hormone and Bone Morphogenetic Protein 15 on the Proliferation and Progesterone Secretion of Granular Cells].

TGF-β1 Levels in Follicular Fluid of Patients with Endometriosis Associated Infertility

Intestinal Microecology And Expressions Of Serum Fibroblast Growth Factors In Women With Postmenopausal Osteoporosis

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

The Associations Between Expression of GDF-9 and BMP-15 in Oocytes and CGC and Different Ovarian Responses

miR-15a-5p levels correlate with poor ovarian response in human follicular fluid.

[Correlation Between Follicle-Stimulating Hormone and Total Procollagen I N-terminal Propeptide in Perimenopausal Women].

Stage-specific Expression of Bone Morphogenetic Protein Type I and Type II Receptor Genes: Effects of Follicle-Stimulating Hormone on Ovine Antral Follicles

[Follicle-Stimulating Hormone Receptor Levels in Relation to Ovarian Cycling Response from Gonadotropin Hormone Stimulation]

Elevated Follicular Cortisone Level is a Negative Predictor of Clinical Pregnancy in Women Undergoing Fresh Embryo Transfer

The Exploration of Poor Ovarian Response-Related Risk Factors: A Potential Role of Growth Differentiation Factor 8 in Predicting Ovarian Response in IVF-ET Patient

Application of specific ELISAs for BMP15 and GDF9 to cumulus cell extracts from infertile women

[Change and Significance of Growth Differentiation Factor 9 and Bone Morphogenetic Protein Expression During Oocyte Maturation in Polycystic Ovary Syndrome Patients with Ovarian Stimulation].

Comparative Analyses in Transcriptome of Human Granulosa Cells and Follicular Fluid Micro-Environment Between Poor Ovarian Responders with Conventional Controlled Ovarian or Mild Ovarian Stimulations

Association of Basal Serum Testosterone Levels with Ovarian Response and in Vitro Fertilization Outcome

Age and Expression of Follicle-stimulating Hormone Receptor in Granulosa Cells